Toxoplasmosis in pregnancy and its transmission to the fetus.
D000293:Adolescent; D000328:Adult; D005260:Female; D005865:Gestational Age; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007933:Leucomycins / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange; D010297:Paris; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology*; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014122:Toxoplasma / Q000302:isolation & purification; D014123:Toxoplasmosis / Q000188:drug therapy / Q000453:epidemiology*; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy / Q000453:epidemiology*
D007933:Leucomycins; D013411:Sulfadiazine; D011739:Pyrimethamine